Stay updated on Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.
Latest updates to the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page
- Check4 days agoChange DetectedAdded Melanoma and MedlinePlus Genetics as related topics on the study page. These additions serve as metadata for context and indexing.SummaryDifference0.2%
- Check11 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed in the page header, a minor versioning update that does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check19 days agoChange DetectedThe page deleted the government funding notice and operating status details and removed related topic links (Melanoma; MedlinePlus Genetics). Core study content including title, condition, pembrolizumab intervention, study design, eligibility criteria, and outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%
- Check33 days agoChange DetectedThe new screenshot shows only minor visual adjustments and slight rearrangement of non-critical sections; core trial details, eligibility criteria, endpoints, and overall study status remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check40 days agoChange DetectedAdded related topics: Melanoma and MedlinePlus Genetics, expanding contextual links on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check47 days agoChange DetectedRemoved a MedlinePlus Genetics topic: Melanoma.SummaryDifference0.2%
Stay in the know with updates to Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.